Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades
The Dermatology Digest
NOVEMBER 1, 2021
Specifically, between 2001 and 2011, conventional systemics and biologics were used primarily in adolescents. The current era, with more pediatric patients included in therapeutic trials and thus more objective safety and efficacy data, features the approval of several systemic therapeutic options for pediatric psoriasis.
Let's personalize your content